• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Aelis Farma

Recent news which mentions Aelis Farma

After Four Weeks, New Drug Shows Promising Results In Boosting Life Skills For Down Syndrome Patients
November 20, 2024
Tickers NEWS
Tags Torre Fornell Market News Benzinga
From Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
September 04, 2024
Tickers CDU INDV NEWS
Tags News Cannabis INDV
From Benzinga
Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
June 09, 2023
Tags Aelis Farma Benzinga cannabis use disorder
From Benzinga
Aelis Farma's Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome
November 17, 2022
Tags Market News Aelis Farma premium
From Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
June 01, 2022
Tickers INVVY
Tags Cannabis News Markets
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap